NORTHWEST BIOTHERAPEUTICS INC
NWBONorthwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton.
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How NWBO's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Shenwu Capsule | Phase 3 | Mild Cognitive Impairment | - | - |
Lithium Carbonate | Phase 2 | Major Depressive Disorder | - | - |
Frequently asked questions
What is in NORTHWEST BIOTHERAPEUTICS INC's drug pipeline?→
CatalystAlert tracks 2 drug candidates in NORTHWEST BIOTHERAPEUTICS INC's (NWBO) pipeline across Phase 3, Phase 2. Its lead program is Shenwu Capsule (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is NORTHWEST BIOTHERAPEUTICS INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for NORTHWEST BIOTHERAPEUTICS INC (NWBO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track NWBO biotech catalysts?→
Add NWBO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NORTHWEST BIOTHERAPEUTICS INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.